A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine. With 28 study sites around the world, it is the largest…
Gene Identified That Increases Risk of Antibiotic Reaction
Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin. Routine testing for this gene could improve patient safety and reduce unnecessary avoidance of other antibiotics, they reported in the Journal of Allergy and Clinical Immunology.…
Discovery Could Neutralize West Nile Virus
Investigators Find That Bile Acids Reduce Cocaine Reward
Study Reveals Opioid Patients Face Multiple Barriers to Treatment
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found. While the opioid crisis has escalated across the U.S., there has been growing concern that treatment capacity has not kept pace.…
